The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 9, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

September 14, 2027

Conditions
Hip FractureAnemia
Interventions
DRUG

Ferric Derisomaltose

The active intervention is a single dose of Ferric Derisomaltose, 20mg/kg body weight, diluted in 100 mL isotonic sodium chloride 0.9%

DRUG

Saline (NaCl 0,9 %) (placebo)

Single dose of 100 mL isotonic sodium chloride 0.9%

Trial Locations (3)

2400

RECRUITING

Department of Orthopedic Surgery and Traumatology, Bispebjerg, Copenhagen University Hospital, Copenhagen NV

2730

RECRUITING

Department of Orthopedic Surgery and Traumatology, Herlev, Copenhagen University Hospital, Herlev

5000

NOT_YET_RECRUITING

Department of Orthopaedic Surgery, Odense and Svendborg University Hospital, Odense C

All Listed Sponsors
collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Copenhagen University Hospital at Herlev

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Musculoskeletal Statistics Unit, The Parker Institute

UNKNOWN

collaborator

Svendborg Hospital

OTHER

lead

Soren Overgaard

OTHER